Medpace CEO August J. Troendle disposes of 650 shares worth $403,175.50
MEDP•Medpace CEO sells shares
Medpace Holdings President and CEO August J. Troendle sold 650 common shares on Aug. 27, 2026.
The sale was priced at $620.27 per share.
Following the transaction, direct holdings fell to 539,894 shares.
Medpace Investors, LLC reported 4,733,019 shares held indirectly.




